Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125168653 | 12516865 | 3 | F | 20160407 | 20160722 | 20160630 | 20160804 | EXP | GB-TEVA-671481ACC | TEVA | 41.00 | YR | F | Y | 0.00000 | 20160804 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125168653 | 12516865 | 1 | PS | DOXYCYCLINE. | DOXYCYCLINE | 1 | Unknown | UNK | U | U | 62497 | ||||||||
125168653 | 12516865 | 2 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | U | 0 | |||||||||
125168653 | 12516865 | 3 | SS | TYVERB | LAPATINIB | 1 | Unknown | U | U | 0 | INJECTION | ||||||||
125168653 | 12516865 | 4 | SS | CLEXANE | ENOXAPARIN SODIUM | 1 | Subcutaneous | U | 0 | INJECTION | |||||||||
125168653 | 12516865 | 5 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | U | 0 | ||||||||||
125168653 | 12516865 | 6 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | U | 0 | ||||||||||
125168653 | 12516865 | 7 | SS | LOPERAMIDE | LOPERAMIDE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125168653 | 12516865 | 1 | Acne |
125168653 | 12516865 | 2 | Product used for unknown indication |
125168653 | 12516865 | 3 | Product used for unknown indication |
125168653 | 12516865 | 4 | Product used for unknown indication |
125168653 | 12516865 | 5 | Product used for unknown indication |
125168653 | 12516865 | 6 | Product used for unknown indication |
125168653 | 12516865 | 7 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125168653 | 12516865 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125168653 | 12516865 | Abasia | |
125168653 | 12516865 | Acne | |
125168653 | 12516865 | Anxiety | |
125168653 | 12516865 | Contusion | |
125168653 | 12516865 | Depression | |
125168653 | 12516865 | Diarrhoea | |
125168653 | 12516865 | Dyspnoea | |
125168653 | 12516865 | Eating disorder | |
125168653 | 12516865 | Fatigue | |
125168653 | 12516865 | Gastritis | |
125168653 | 12516865 | Headache | |
125168653 | 12516865 | Inflammatory pain | |
125168653 | 12516865 | Insomnia | |
125168653 | 12516865 | Malaise | |
125168653 | 12516865 | Muscle spasms | |
125168653 | 12516865 | Onychalgia | |
125168653 | 12516865 | Oropharyngeal pain | |
125168653 | 12516865 | Pain in extremity | |
125168653 | 12516865 | Peripheral swelling | |
125168653 | 12516865 | Plantar erythema | |
125168653 | 12516865 | Pruritus | |
125168653 | 12516865 | Speech disorder | |
125168653 | 12516865 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125168653 | 12516865 | 1 | 20160324 | 0 |